Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
BridgeBio Pharma
BBIO
Revenue recognized that was included in deferred income at the beginning of the period
Revenue recognized that was included in deferred income at the beginning of the period at other companies
Antero Resources
AR
$5.8M
-7.0%
Ally Financial
ALLY
$225M
+5.1%
Ally Financial
ALLY
$239M
+0.4%
Hyatt Hotels
H
$181M
+7.7%
Moderna
MRNA
$37M
+363%
Baxter International
BAX
$182M
+46.8%
Segments
By product
See full
License and services revenue
$2.1M
-8.7%
Other financials
Income statement
See full
Revenue
$194.5M
+66.8%
Gross profit
$184.6M
+61.9%
Operating income
-$106.0M
-1.5%
Net income
-$166.6M
+1.8%
EPS (diluted)
-$0.84
+4.5%
Balance sheet
See full
Cash & equivalents
$882.0M
+62.5%
Total debt
$3.3B
+32,101%
Total equity
-$2.3B
-38.2%
Total assets
$1.4B
+55.5%
Cash flow
See full
Operating cash flow
-$197.3M
+1.0%
CapEx
$69.0K
—
Free cash flow
-$197.3M
+0.9%
Valuation
See full
Market cap
$12.98B
+119%
Enterprise value
$15.36B
+178%
P/S
22.4×
-24.1×
Profitability
See full
Gross margin
95.1%
-0.2pp
Operating margin
-90.5%
-41.2pp
Net margin
-125.9%
-54.5pp
FCF margin
-76.8%
—
Returns & leverage
See full
Return on equity
-216.8%
—
Debt / equity
2×
—
Current ratio
1.5×
-3.0×